检索结果-南通市图书馆

CEPC Technical Design Report

在线全文

学校读者我要写书评

暂无评论

Radiation Detection Technology and Methods 2024年第1期8卷 I0003-I0016,1-1091页

作者： Waleed Abdallah Tiago Carlos Adorno de Freitas Konstantin Afanaciev Shakeel Ahmad Ijaz Ahmed Xiaocong Ai Abid Aleem Wolfgang Altmannshofer Fabio Alves Weiming An Rui An Daniele Paolo Anderle Stefan Antusch Yasuo Arai Andrej Arbuzov Abdesslam Arhrib Mustafa Ashry Sha Bai Yu Bai yang Bai Vipul Bairathi Csaba Balazs Philip Bambade Yong Ban Tripamo Bandyopadhyay Shou-Shan bao Desmond P.Barber Ayse Bat Varvara Batozskaya Subash Chandra Behera Alexander Belyaev Michele Bertucci Xiao-Jun Bi Yuanjie Bi Tianjian Bian Fabrizio Bianchi Thomas Biekotter Michela Biglietti Shalva Bilanishvili Deng Binglin Denis Bodrov Anton Bogomyagkov Serge Bondarenko Stewart Boogert Maarten Boonekamp Marcello Borri Angelo Bosotti Vincent Boudry Mohammed Boukidi Igor Boyko Ivanka Bozovic Giuseppe Bozzi Jean-Claude Brient Anastasiia Budzinskaya Masroor Bukhari Vladimir Bytev Giacomo Cacciapaglia hua Cai Wenyong Cai Wujun Cai Yijian Cai Yizhou Cai Yuchen Cai Haiying Cai huacheng Cai Lorenzo Calibbi Junsong Cang Guofu Cao jianshe Cao Antoine Chance Xuejun Chang Yue Chang Zhe Chang Xinyuan Chang Wei Chao Auttakit Chatrabhuti Yimin Che Yuzhi Che Bin Chen Danping Chen Fuqing Chen Fusan Chen Gang Chen Guoming Chen hua-Xing Chen Huirun Chen Jinhui Chen Ji-Yuan Chen Kai Chen Mali Chen Mingjun Chen Mingshui Chen Ning Chen Shanhong Chen Shanzhen Chen Shao-Long Chen Shaomin Chen Shiqiang Chen Tianlu Chen Wei Chen Xiang Chen Xiaoyu Chen Xin Chen Xun Chen Xurong Chen Ye Chen Ying Chen Yukai Chen Zelin Chen Zilin Chen Gang Chen Boping Chen Chunhui Chen Hok Chuen cheng huajie cheng Shan cheng Tongguang cheng yunlong Chi Pietro Chimenti Wen Han Chiu Guk Cho Ming-Chung Chu Xiaotong Chu Ziliang Chu Guglielmo Coloretti Andreas Crivellin Hanhua Cui Xiaohao Cui Zhaoyuan Cui Brunella D'Anzi ling-yun Dai Xinchen Dai Xuwen Dai Antonio De Maria Nicola De Filippis Christophe De La Taille Francesca De Mori Chiara De Sio Elisa Del Core Shuangxue Deng Wei-Tian Deng Zhi Deng Ziyan Deng Bhupal Dev Tang Dewen Biagio Di Micco Ran Ding Siqin Dingl Yadong Ding Haiyi Dong jianin AGH University of Science and Technology Faculty of Physics and Applied Computer ScienceKrakow Anhui University HefeiAnhui Applied Physics Department Federal Urdu University of ArtsScience and TechnologyIslamabad Banaras Hindu University Institute of ScienceVaranasi Bandirma Onyedi Eylul University Bandirma Beihang University Beijing Beijing Computational Science Research Center Beijing Beijing Conveyi LTD Beijing Beijing Glass Research Institute Co. LtdBeijing Beijing Institute of Technology Beijing Beijing Normal University Beijing Brown University ProvidenceRI Budker Institute of Nuclear Physics Novosibirsk Cadi Ayyad University Laboratory of Fundamental and Applied PhysicsPolydisciplinary FacultyMarrakech Cairo University Giza Center for Theory and Computation National Tsing Hua UniversityHsinchu Central China Normal University WuhanHubei Central South University ChangshaHunan Centro de Fisica Teorica de Particulas Universidade Tecnica de LisboaLisboa chengdu KaitengSifang Digital Radio&TV Equipment Co. LtdChengduSichuan China academy of engineering physics MianyangSichuan China building materials academy Beijing China Center of Advanced Science and Technology Beijing China Institute of Atomic Energy Beijing China Jiliang University HangzhouZhejiang China Nuclear Instrument CO. LTDBeijing China University of Geosciences Beijing China University of Geosciences WuhanHubei China University of Mining and Technology XuzhouJiangsu China West Normal University NanchongSichuan Chongqing University Department of PhysicsChongqing Chulalongkorn University Bangkok City University of Hong Kong Department of PhysicsHong Kong Cockcroft Institute Daresbury Cornell University IthacaNY CPPM(AMU/IPhU&CNRS/INP) Marseille Dalian Minzu University DalianLiaoning Dalian University of Technology Department of PhysicsDalian Deutsches Elektronen-Synchrotron DESY Hamburg Dzhelepov Laboratory of Nuclear Problems of Joint Institute for Nuclear Research(DLNP JINR) Dubna East China University Of Science And Technol

The Circular Electron Positron Collider(CEPC)is a large scientific project initiated and hosted by China,fostered through extensive collaboration with international *** complex comprises four accelerators:a 30 GeV linac,a 1.1 GeV Damping Ring,a Booster capable of achieving energies up to 180 GeV,and a Collider operating at varying energy modes(Z,W,H,and tt).The linac and Damping Ring are situated on the surface,while the subterranean Booster and Collider are housed in a 100 km circumference underground tunnel,strategically accommodating future expansion with provisions for a potential Super Proton Proton Collider(SPPC).The CEPC primarily serves as a Higgs *** its baseline design with synchrotron radiation(SR)power of 30 MW per beam,it can achieve a luminosity of 5×10^(34)cm^(-2)s^(-1)per interaction point(IP),resulting in an integrated luminosity of 13 ab^(-1)for two IPs over a decade,producing 2.6 million Higgs *** the SR power to 50 MW per beam expands the CEPC's capability to generate 4.3 million Higgs bosons,facilitating precise measurements of Higgs coupling at sub-percent levels,exceeding the precision expected from the HL-LHC by an order of *** Technical Design Report(TDR)follows the Preliminary Conceptual Design Report(Pre-CDR,2015)and the Conceptual Design Report(CDR,2018),comprehensively detailing the machine's layout,performance metrics,physical design and analysis,technical systems design,R&D and prototyping efforts,and associated civil engineering ***,it includes a cost estimate and a preliminary construction timeline,establishing a framework for forthcoming engineering design phase and site selection *** is anticipated to begin around 2027-2028,pending government approval,with an estimated duration of 8 *** commencement of experiments and data collection could potentially be initiated in the mid-2030s.

关键词： initiated exceeding precise

Efficacy and safety of sirolimus early conversion protocol in liver transplant patients with hepatocellular carcinoma:A single-arm, multicenter, prospective study

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Hepatobiliary & Pancreatic Diseases International 2022年第2期21卷 106-112页

作者： ren-Yi Su Sun-Bin ling Qiao-Nan Shan Xu-Yong Wei Rui Wang Chang-Ku Jia li Zhuang Tian Shen li-Min Ding Zhi-Dan Xu Lai-Bang Luo li-Bo Sun Guang-Ming li Tai-Shi Fang Nan jiang Kun Zhang Zhao-Jie Su Zhi-Hai Peng ren Lang Tao jiang Qiang He lin-Sen Ye yang yang Yu-Ting He Wen-Zhi Guo liu-gen Lan Xu-Yong Sun Dong Chen Zhi-Shui Chen Da-Wei Zhou Shao-Jun Ye Qi-Fa Ye Min Tian jian-hua Shi Bo Wang jiang liu Qian Lu Wei Rao Jin-Zhen Cai Tao Lv Jia-Yin yang Pu-Sen Wang lin Zhong Jing-Sheng Ma Qi-gen li Sheng-Dong Wu Chang-jiang Lu Cai-De Lu Dong-hua Zhang Xuan Wang Zi-Qiang li Mu-jian Teng Jun-Jie li Wen-Tao jiang jian-hua li Quan-bao Zhang Ning-Qi Zhu zheng-Xin Wang Kang He Qiang Xia Shao-hua Song Zhi-ren Fu Wei qiu Guo-Yue Lv Rui-Peng Song Ji-Zhou Wang zheng Wang jian Zhou Gang Chen Ying-Peng Zhao li li Ze-Min Hu Qi-Jie Luo Zhong-Zhou Si Bin Xie Xiao-Shun He Zhi-Yong Guo Shu-Sen zheng Xiao Xu Department of Hepatobiliary and Pancreatic Surgery The Center for Integrated Oncology and Precision MedicineAffiliated Hangzhou First People’s HospitalZhejiang University School of MedicineHangzhou 310006China NHC Key Laboratory of Combined Multi-organ Transplantation Hangzhou 310003China Department of Hepatobiliary and Pancreatic Surgery Shulan(Hangzhou)HospitalZhejiang Shuren University School of MedicineHangzhou 310022China Department of Hepatobiliary and Pancreatic Surgery The First Affiliated HospitalZhejiang University School of MedicineHangzhou 310003China Department of Transplantation Jiangxi Provincial People’s Hospital Affiliated to Nanchang UniversityNanchang 330006China liver Transplantation Center Beijing You’an HospitalCapital Medical UniversityBeijing 100069China Department of Hepatic Surgery National Clinical Research Center for Infectious DiseaseShenzhen Third People’s HospitalThe Second Affiliated Hospital of Southern University of Science and TechnologyShenzhen 518112China Department of general Surgery Xiang’an Hospital of Xiamen UniversityXiamen 361000China Deartment of Hepatobiliary and Pancreaticosplenic Surgery Beijing Chaoyang HospitalCapital Medical UniversityBeijing 100020China Department of Hepatic Surgery and liver Transplantation Center The Third Affiliated Hospital of Sun Yat-sen UniversityGuangzhou 510630China Department of Hepatobiliary and Pancreatic Surgery The First Affiliated Hospital of Zhengzhou UniversityZhengzhou 450052China Department of liver Transplantation The Second Affiliated Hospital of Guangxi Medical UniversityNanning 530000China Institute of Organ Transplantation Tongji HospitalTongji Medical CollegeHuazhong University of Science and TechnologyWuhan 430030China Institute of Hepatobiliary Diseases of Wuhan University Transplant Center of Wuhan UniversityHubei Key Laboratory of Medical Technology on TransplantationZhongnan Hospital of Wuhan UniversityWuhan 430071China Department of Hepatobiliary Surgery The First Affiliated Hos

Mammalian target of rapamycin(m TOR) inhibitor as an attractive drug target with promising antitumor effects has been widely investigated. High quality clinical trial has been conducted in liver transplant(LT) recipients in Western countries. However, the pertinent studies in Eastern world are paucity. Therefore, we designed a clinical trial to test whether sirolimus can improve recurrence-free survival(RFS) in hepatocellular carcinoma(HCC) patients beyond the Milan criteria after LT. This is an open-labeled, single-arm, prospective, multicenter, and real-world study aiming to evaluate the clinical outcomes of early switch to sirolimus-based regimens in HCC patients after LT. Patients with a histologically proven HCC and beyond the Milan criteria will be enrolled. The initial immunosuppressant regimens are center-specifc for the frst 4-6 weeks. The following regimens integrated sirolimus into the regimens as a combination therapy with reduced calcineurin inhibitors based on the condition of patients and centers. The study is planned for 4 years in total with a 2-year enrollment period and a 2-year follow-up. We predict that sirolimus conversion regimen will provide survival benefts for patients particular in the key indicator RFS as well as better quality of life. If the trial is conducted successfully, we will have a continued monitoring over a longer follow-up time to estimate indicator of overall survival. We hope that the outcome will provide better evidence for clinical decision-making and revising treatment guidelines based on Chinese population data.

关键词： Sirolimus Immunosuppressive agents Hepatocellular carcinoma liver transplantation Conversion

A double-blind,randomized,placebo-and positive-controlled phase III trial of 1% benvitimod cream in mild-to-moderate plaque psoriasis

在线全文

学校读者我要写书评

暂无评论

Chinese Medical Journal 2020年第24期133卷 2905-2909页

作者： lin Cai gen-Hui Chen Qian-Jin Lu Min zheng Yu-Zhen li Jin Chen Jie zheng Fu-ren Zhang jian-Bin Yu Sen yang Fu-qiu li Sheng-Xiang Xiao qiu-Ning Sun Jin-hua Xu Xing-hua Gao Hong Fang Tian-Wen Gao Fei Hao Quan-Zhong liu Ya-Ting Tu Ruo-Yu li bao-Xi Wang Dan-Qi Deng Qing-Shan zheng Hong-Xia liu jian-Zhong Zhang Department of Dermatology Peking University People’s HospitalBeijing 100044China Beijing Wenfeng Tianji Pharma Ltd. Beijing 100044China Department of Dermatology The Second Xiangya HospitalCentral South UniversityChangshaHunan 410011China Department of Dermatology The Second Affiliated Hospital of Zhejiang University School of MedicineHangzhouZhejiang 310009China Department of Dermatology Harbin Medical University Second HospitalHarbinHeilongjiang 150001China Department of Dermatology Sichuan Provincial People’s HospitalChengduSichuan 610072China Department of Dermatology Shanghai JiaoTong University School of Medicine Ruijin HospitalShanghai 213002China Shandong Provinical Institute of Dermatology and Venereology JinanShandong 250022China Department of Dermatology The First Affiliated HospitalZhengzhou UniversityZhengzhouHenan 450052China Department of Dermatology The First Affiliated HospitalAnhui Medical UniversityHefeiAnhui 230022China Department of Dermatology The Second Hospital of Jilin UniversityChangchunJilin 130041China Department of Dermatology The Second Affiliated HospitalXi’an Jiaotong UniversityXi’anShaanxi 710004China Department of Dermatology Peking Union Medical College HospitalBeijing 100730China Department of Dermatology Fudan University Huashan HospitalShanghai 200041China Department of Dermatology The First Hospital of China Medical UniversityShenyangLiaoning 110001China Department of Dermatology The First Affiliated HospitalZhejiang UniversityHangzhouZhejiang 310006China Department of Dermatology Xijing HospitalAir Force Medical University of People’s Liberation ArmyXi’anShaanxi 710032China Department of Dermatology Southwest HospitalThird Military Medical University(Army Medical University)Chongqing 400038China Department of Dermatology Tianjin Medical University General HospitalTianjin 300052China Department of Dermatology Wuhan Union HospitalWuhanHubei 430022China Department of Dermatology Peking University First HospitalBeijing

Background:Benvitimod cream,a novel synthetic small molecule,was effective in treating mild-to-moderate plaque *** conducted a phase III clinical trial to assess the efficacy and safety of benvitimod cream in patients with mild-to-moderate plaque ***:We randomly assigned 686 patients(2:1:1)to receive 1%benvitimod cream,0.005%calcipotriol ointment or placebo twice a day for 12 *** primary efficacy end points were the percentage of patients with a 75%or greater reduction from baseline in the psoriasis area and severity index(PASI 75)score and with a score of 0 or 1 in static physician’s global assessment(sPGA)at week ***:The results showed that 50.4%of patients in the benvitimod group achieved PASI 75,which was significantly higher than that in the calcipotriol(38.5%,Plication site irritation,follicular papules,and contact *** systemic adverse reactions were ***:During this 12-week study,benvitimod cream was demonstrated with high effectiveness and safety in patients with mild-to-moderate plaque psoriasis.

关键词： Psoriasis Benvitimod Immune modulator Drug discovery 3,5-dihydroxy-4-isopropylstilbene

Volunteer running enhances oligodendrocyte regeneration and myelin repair after cuprizone-induced demyelination

在线全文

学校读者我要写书评

暂无评论

Volunteer running enhances oligodendrocyte regeneration and ...

秸秆全量还田与氮肥运筹对机插粳稻产量及氮素吸收利用的影响

中国神经科学学会第十二届全国学术会议

作者： jian zheng Rui-hua ren Xuan Sun qiu-Hui-Hong Yu Fei Luo Chao-lin Ma bao-Ming li Center for Neuropsychiatric Disorders Institute of Life Science Nanchang University School of Basic Medical Sciences Nanchang University

Objective The effect of volunteer running on myelin disturbances is unknown. The present study examined the effects of volunteer running on oligodendrocyte regeneration and myelin repair in a demyelination animal model. Methods C57 BL/6 mice were fed with cuprizone（0.2% w/w） for 12 weeks to induce chronic demyelination and oligodendrocyte degeneration, after which cuprizone was withdrawn to allow recovery. The mice were allowed to running freely in the wheels. Locomotor activities were used to evaluate behavioral changes in the mice. Immunohistochemical staining was used to detect morphological and biological changes in the brains. Cuprizone administration for 12 weeks resulted in severe demyelination, locomotor deficits in mice. Remyelination occurred when cuprizone was withdrawn. Results（1） Volunteer running during the recovery period significantly improved the locomotor activities and increased myelin restoration.（2） Volunteer running also enhanced the repopulation of mature oligodendrocytes in the demyelinated lesions, which was accompanied by reduction of mature oligodendrocytes. Conclusion This study supports the role of oligodendrocyte dysfunction in activity deficits in a cuprizone mouse model and suggests that volunteer running may target oligodendrocytes and improve cognitive function.

关键词： volunteer running remyelination cuprizone oligodendrocyte

来源： cnki会议评论

在线全文

cnki会议

学校读者我要写书评

暂无评论

作物学报 2017年第6期43卷 912-924页

作者：李晓峰程金秋梁健陈梦云任红茹张洪程霍中洋戴其根许轲魏海燕郭保卫扬州大学农业部长江流域稻作技术创新中心/扬州大学江苏省作物遗传生理国家重点实验室培育点江苏扬州225009

以常规粳稻南粳5055、南粳46为材料,在总施纯氮量为300 kg hm–2条件下,设置9∶1、8∶2、7∶3、6∶4、5∶5、4∶6共6种基蘖肥与穗肥比例,探讨秸秆全量还田条件下不同氮肥运筹对机插粳稻产量及氮素吸收利用特征的影响。结果表明,与秸秆... 详细信息

以常规粳稻南粳5055、南粳46为材料,在总施纯氮量为300 kg hm–2条件下,设置9∶1、8∶2、7∶3、6∶4、5∶5、4∶6共6种基蘖肥与穗肥比例,探讨秸秆全量还田条件下不同氮肥运筹对机插粳稻产量及氮素吸收利用特征的影响。结果表明,与秸秆不还田相比,秸秆全量还田具有显著的增产效应,南粳5055、南粳46平均增产5.04%、4.64%;随着基蘖氮肥占总施氮量比例的下降,秸秆全量还田机插粳稻产量呈先增后减的趋势,基蘖氮肥与穗氮肥比例为7∶3时,水稻产量最高。相同氮肥运筹模式下,秸秆全量还田处理水稻拔节期及移栽至拔节阶段的群体干物质积累量均低于秸秆不还田处理,抽穗期、成熟期及拔节至抽穗、抽穗至成熟阶段的群体干物质积累量则高于秸秆不还田处理。氮肥运筹间表现为随基蘖氮肥占总施氮量比例的下降,拔节期及移栽至拔节阶段的群体干物质积累量下降,而抽穗期、成熟期及拔节至抽穗、抽穗至成熟阶段的群体干物质积累量呈现先增后减的趋势。当基蘖氮肥与穗氮肥比例为7∶3时,秸秆全量还田条件下的水稻群体干物质积累量最高,经济系数也最高。秸秆全量还田水稻拔节前的氮素积累量低于秸秆不还田处理,拔节至抽穗、抽穗至成熟阶段的氮素积累量则高于秸秆不还田处理,秸秆全量还田处理的氮肥表观利用率、氮肥农学利用率和氮肥偏生产力均高于秸秆不还田处理。不同氮肥运筹间表现为随基蘖肥占总施氮量比例的下降,氮肥表观利用率、氮肥农学利用率、氮肥生理利用率及氮肥偏生产力均呈现先增后减的趋势,当基蘖氮肥与穗氮肥运筹比例为7∶3时最高。

关键词：秸秆全量还田氮肥运筹机插粳稻产量氮素吸收氮肥利用率

老龄小鼠卵母细胞发育过程中组蛋白乙酰化修饰的改变

在线全文

学校读者我要写书评

暂无评论

动物学报 2007年第6期53卷 1069-1075页

作者：王丹秋于建宁李少华邵根宝刘红林南京农业大学动物科技学院南京210095

分别取年轻C57/B6雌性小鼠(3-4周龄)与老龄C57/B6雌性小鼠(40-42周龄)不同发育时期的卵母细胞,利用免疫荧光技术观察其组蛋白不同赖氨酸位点乙酰化的变化,并用RT-PCR法检测年轻小鼠与老龄小鼠卵母细胞不同发育时期Hdac1与Hdac3(组蛋白... 详细信息

分别取年轻C57/B6雌性小鼠(3-4周龄)与老龄C57/B6雌性小鼠(40-42周龄)不同发育时期的卵母细胞,利用免疫荧光技术观察其组蛋白不同赖氨酸位点乙酰化的变化,并用RT-PCR法检测年轻小鼠与老龄小鼠卵母细胞不同发育时期Hdac1与Hdac3(组蛋白去乙酰化酶)mRNA的相对表达量。结果显示:(1)年轻小鼠和老龄小鼠卵母细胞组蛋白H4/K12、H4/K16、H4/K5及H3/K14的乙酰化水平均随发育进程逐渐升高,在完全生长期乙酰化水平达到峰值,至MⅡ期,除H4/K12外,其它三个位点的乙酰化全部消失;与年轻小鼠相比,完全生长期时老龄小鼠卵母细胞组蛋白乙酰化水平较低;(2)在完全生长期之前,年轻小鼠和老龄小鼠卵中Hdac-1与Hdac-3 mRNA的表达量呈逐渐降低趋势,但老龄小鼠在MⅡ期有所升高。与年轻小鼠相比,老龄小鼠完全生长期前各时期卵母细胞中Hdac1 mRNA的表达量均极显著降低(P<0.01);而Hdac3 mRNA的表达量二者之间无显著差异。结果表明:老龄小鼠卵母细胞中组蛋白乙酰化和组蛋白去乙酰化酶表达出现了异常变化。

关键词：老龄小鼠卵母细胞退化组蛋白乙酰化 Hdac1 Hdac3 荧光实时定量PCR

在线全文

学校读者我要写书评

暂无评论

基于电子鼻的鲫鱼肉新鲜度研究

食品工业科技 2014年第19期35卷 284-288页

作者：李越华包建强周秋淑俞所银任青黄雯上海海洋大学食品学院上海201306 烟台大学海洋学院山东烟台264005

利用电子鼻对冷藏(4℃)和微冻(-3℃)贮藏下的鲫鱼肉挥发性气味变化进行了研究,对所获得的数据进行主成分分析(Principal Component Analysis,PCA)和判别因子分析(Discriminant Factor Analysis,DFA),并将样品气味感官评分和电子鼻测得... 详细信息

利用电子鼻对冷藏(4℃)和微冻(-3℃)贮藏下的鲫鱼肉挥发性气味变化进行了研究,对所获得的数据进行主成分分析(Principal Component Analysis,PCA)和判别因子分析(Discriminant Factor Analysis,DFA),并将样品气味感官评分和电子鼻测得的数据结合,进行偏最小二乘回归分析(PLS),建立一种基于电子鼻的判别鲫鱼新鲜度方法。结果表明:PCA和DFA分析均能将冷藏和微冻贮藏下的样品,随贮藏时间延长,挥发性气味的变化有效区分开,第一和第二主成分累计贡献率分别达到99.797%和99.425%。DF1和DF2累计贡献率达到99.263%和97.807%。气味感官评分和电子鼻数据经偏最小二乘回归分析(PLS),相关系数(R2)达到0.9976和0.9887,存在高度的相关性。因此电子鼻可以将冷藏和微冻贮藏下,不同新鲜度的鲫鱼区分开。冷藏样品的区分效果优于微冻样品。

关键词：冷藏微冻鲫鱼新鲜度电子鼻

在线全文

学校读者我要写书评

暂无评论

排卵后老化卵母细胞的染色体形态变化

遗传 2007年第2期29卷 225-229页

作者：于建宁王蒙王丹秋李少华邵根宝吴彩凤刘红林南京农业大学动物科技学院南京210095

小鼠排卵后的卵母细胞停滞在MⅡ期,如果此时的卵母细胞未能及时受精,随着在输卵管中停留时间的延长,卵母细胞会逐渐发生老化。这种卵母细胞的老化会导致包括人在内的哺乳动物的胚胎发育异常,所以很有必要研究排卵后卵母细胞的老化机理... 详细信息

小鼠排卵后的卵母细胞停滞在MⅡ期,如果此时的卵母细胞未能及时受精,随着在输卵管中停留时间的延长,卵母细胞会逐渐发生老化。这种卵母细胞的老化会导致包括人在内的哺乳动物的胚胎发育异常,所以很有必要研究排卵后卵母细胞的老化机理。本实验主要研究小鼠排卵后的卵母细胞在体内老化过程中的染色体形态变化,发现随着老化时间的延长,有更高比例(65%,hCG后34h)的卵母细胞的染色体呈不对称和松散的状态,进一步研究表明,这种染色体的变化可能与H3K14、H4K16的乙酰化升高,及H3K9的甲基化降低有关。

关键词：卵母细胞老化染色体组蛋白乙酰化甲基化

在线全文

学校读者我要写书评

暂无评论

遗传性耳聋基因治疗临床指南

实用医院临床杂志 2024年第2期21卷 39-44页

作者：齐洁玉谈方志张李燕陆玲王洪阳李文妍刘闻闻付小龙贺祖宏丁小琼孙珊方巧军董耀东朱学伟童步升曹现宝郭敏范欣淼汪芹马璐张天虹于亚峰李永新樊建刚崔勇吴佩娜张宏征唐杰郭维维查定军叶放蕾何双八曹卫杨见明钱晓云赵宇孙敬武陈晓巍孙宇夏明王秋菊袁慧军冯永孔维佳杨仕明王海波高下李华伟徐磊柴人杰东南大学数字医学工程全国重点实验室附属中大医院耳鼻咽喉头颈外科生命科学与技术学院生命与健康高等研究院江苏省生物医学高新技术研究重点实验室江苏南京210096 南通大学神经再生联合创新中心江苏南通226001 北京理工大学航天中心医院神经内科生命学院北京10081 南京大学医学院附属鼓楼医院耳鼻喉头颈外科江苏省医学重点学科(实验室)江苏南京210008 中国人民解放军总医院耳鼻咽喉头颈外科医学部北京100853 听觉与平衡觉全国重点实验室北京100853 国家耳鼻咽喉疾病临床医学研究中心北京100853 聋病教育部重点实验室北京100853 聋病防治北京市重点实验室北京100853 复旦大学附属眼耳鼻喉科医院医学神经生物学国家重点实验室教育部脑科学前沿研究中心上海200031 复旦大学生物医学研究所上海200032 国家卫健委听觉医学重点实验室上海200031 复旦大学脑科学研究院和脑科学协同创新中心上海200032 山东大学山东省耳鼻喉医院耳鼻咽喉头颈外科山东济南250022 山东省耳鼻喉研究所山东济南250022 山东第一医科大学/山东省医学科学院医学科技创新中心山东济南250000 武汉大学中南医院耳鼻咽喉头颈外科湖北武汉430071 东南大学附属中大医院耳鼻咽喉头颈外科江苏南京210009 复旦大学附属眼耳鼻喉科医院耳鼻喉科上海200032 安徽医科大学第二附属医院耳鼻咽喉头颈外科安徽合肥230601 中国医科大学附属盛京医院耳鼻咽喉头颈外科辽宁沈阳110004 吉林大学中日联谊医院耳鼻咽喉头颈外科吉林长春130033 安徽医科大学第一附属医院耳鼻咽喉头颈外科安徽合肥230022 云南省第一人民医院耳鼻喉科云南昆明650032 昆明医科大学第一附属医院耳鼻喉科云南昆明650032 中国医学科学院北京协和医学院北京协和医院耳鼻咽喉科北京100730 中南大学湘雅二医院耳鼻咽喉头颈外科湖南长沙410008 南华大学衡阳医学院基础医学院细胞生物学与遗传学教研室细胞应激生物学衡阳市重点实验室湖南衡阳421001 哈尔滨医科大学附属第一医院黑龙江哈尔滨150001 苏州大学附属第一医院耳鼻咽喉科江苏苏州215006 首都医科大学附属北京同仁医院耳鼻咽喉头颈外科北京100730 四川省医学科学院·四川省人民医院/电子科技大学附属医院耳鼻咽喉头颈外科四川成都610072 广东省人民医院耳鼻咽喉头颈外科/广东省医学科学院/南方医科大学广东广州510080 南方医科大学珠江医院耳鼻咽喉头颈外科广东广州510282 空军军医大学西京医院耳鼻咽喉-头颈外科陕西西安710032 郑州大学第一附属医院耳科河南郑州450000 东南大学医学院附属南京同仁医院耳鼻咽喉头颈外科江苏南京211102 四川大学华西医院耳鼻咽喉头颈外科四川成都610041 中国科学技术大学附属第一医院耳鼻咽喉头颈外科安徽合肥230001 华中科技大学同济医学院附属协和医院耳鼻咽喉头颈外科湖北武汉430022 山东第一医科大学附属山东省立医院耳鼻咽喉科山东济南250021 山东省医学科学院医学科技创新中心山东济南250021 山东大学附属山东省立医院耳鼻咽喉科山东济南250021 国家卫生健康委耳鼻咽喉重点实验室山东济南250021 四川大学华西医院罕见病研究院四川成都6010041 南华大学衡阳医学院南华大学附属妇幼保健院湖南长沙410008 中南大学湘雅医院耳鼻咽喉头颈外科湖南长沙410008 上海人工耳蜗工程技术研究中心上海200031 东南大学深圳研究院广东深圳518063

遗传性耳聋是一种常见的遗传性疾病,新生儿的发病率为1‰~3‰。患者终身携带致病突变,导致不可逆性耳聋,至今尚无临床可用的治疗药物。在部分遗传性耳聋动物模型中,基因治疗已被证实为潜在有效的治疗方法。国内外已开展了多项遗传性耳... 详细信息

遗传性耳聋是一种常见的遗传性疾病,新生儿的发病率为1‰~3‰。患者终身携带致病突变,导致不可逆性耳聋,至今尚无临床可用的治疗药物。在部分遗传性耳聋动物模型中,基因治疗已被证实为潜在有效的治疗方法。国内外已开展了多项遗传性耳聋基因治疗的临床试验。其中,由东南大学附属中大医院牵头,联合国内多家医院成功开展的遗传性耳聋基因治疗临床试验,取得了显著的疗效,并积累了丰富的经验。为规范遗传性耳聋基因治疗并提供临床研究指导,全国多家医院的耳科专家讨论制定了遗传性耳聋基因治疗临床指南,内容涵盖了伦理审查、遗传性耳聋的诊断和入组标准、临床前准备、药物、疗效与安全性评估标准、术后言语康复等。本指南将为耳聋基因治疗的临床诊疗提供规范的理论和技术指导。

关键词：遗传性耳聋基因治疗临床指南